Clinical Trial

Synthetic THC And Blood Pressure

Not Yet Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
To investigate the effects of Dronabinol use on blood pressure and neurovascular physiology
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-13; most recent amendment 2026-05-05.
Trial Details
NCT Number NCT07231965
Lead Sponsor Mayo Clinic
Conditions Blood Pressure
Enrollment 50 participants
Start Date 2026-07
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-07